| Trial ID: | L0236 |
| Source ID: | ChiCTR-IPR-17012258
|
| Associated Drug: |
Orlistat
|
| Title: |
A randomized, open, single center clinical trial of Orlistat in the treatment of nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non-alcoholic fatty liver disease
|
| Interventions: |
treatment group:Orlistat 120mg, 3 times a day;control group:placebo 120mg, 3 times a day;
|
| Outcome Measures: |
hepatic fat fraction;liver pathology;Hepatic fat quantification;liver stiffness;Haematological index;nan
|
| Sponsor/Collaborators: |
The First Affiliated Hospital of Sun Yat-sen University
|
| Gender: |
All
|
| Age: |
1860
|
| Phases: |
Post-market
|
| Enrollment: |
treatment group:100;control group:100;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Randomized parallel controlled trial
|
| Start Date: |
05/08/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
21 August 2017
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=19481
|
